Marquette University, with a generous grant from the Templeton Religion Trust, is pleased to announce a new research initiative on the topics of the self, motivation, and virtue. Approximately ten research proposals at $190,000 each will be funded through this initiative.
The grant competition has four primary aims:
1. To support innovative research on the self, motivation, and virtue.
2. To encourage methodological innovation in the study of the self, motivation, and virtue.
3. To encourage interdisciplinary team work, specifically between social science and humanities.
4. To support scholars new to the investigation of these topics or who have not received funding elsewhere. Research collaborations between younger and more established scholars are especially encouraged.
Research into character and virtue is often conducted by scholars from within a single disciplinary perspective. This disciplinary isolationism is not maximally productive of new knowledge about virtue. To ensure that research funded by this proposal closes the disciplinary gap, successful teams will be comprised of at least one humanist and one scientist who are fully and equally invested in the research project, from its inception to its completion. The aim here is to encourage awardees to think outside of their own disciplinary perspectives, and to broaden their research horizons in ways conducive to creative collaborations and results.
For more information on this extended deadline, please visit the Marquette University website or contact Marquette at: email@example.com.
New Policy on Individual Developmnet Plans for NIH-Funded Students and Postdocs
The NIH is strongly encouraging institutions to develop institutional policies that employ an Individual Development Plan (IDP) for every graduate student and postdoctoral researcher supported by NIH awards. Beginning on October 1, 2014, the vast majority of NIH funding mechanisms will require that PIs include a description in their annual progress reports of whether the institution uses IDPs or not and how they are employed to help manage the training and career development of those individuals.
A suggested CWRU SOM IDP template will be available shortly. A CWRU SOM on-line IDP submission site will be available by mid-October. The initial submission deadline will be December 1, 2014. It is important to note that the CWRU SOM IDP is a professional development and career planning document for trainees. It is not meant to be or to replace any annual trainee review process that is occurring within your programs.
Please see the document explaining the new CWRU SOM IDP policy. It is written so that PIs, T32 Directors, and others can incorporate aspects of this document into their progress reports. The document can be found here: https://research.case.edu/files/T32_IDP_template.docx
See the Notice here: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-14-113.html.
Department of Defense
OFFICE OF STRATEGIC INITIATIVES - CALL FOR SUBMISSIONS
U.S. Army Medical Research and Materiel Command (USAMRMC) Broad Agency Announcement - BAA -15-1
Apply early. Funding is limited and subject to availability.
The BAA is continuously open, and accepts proposals on a rolling basis. Pre-proposals may be submitted and will be evaluated at any time throughout the year.
Scope: The USAMRMC's mission is to provide solutions to medical problems of importance to the American warfighter. Projects must pertain to at least one of the research areas of interest outlined in the BAA.
Funding: Budgets are not capped and must reflect the scope of the work. Funding can be requested for up to 5 years.
Areas of interest:
1. Military Infectious Diseases Research Program
2. Combat Casualty Care Research Program
3. Military Operational Medicine Research Program
4. Clinical and Rehabilitative Medicine Research Program
5. Medical Biological Defense Research Program
6. Medical Chemical Defense Research Program
7. Medical Simulation and Information Sciences Research Program
8. Radiation Health Effects Research Program
9. Special Investment Areas/Innovation Funding
Office of Strategic Initiatives (OSI): Case School of Medicine's OSI can work with you to make sure that you meet the current goals and objectives of the USAMRMC that is paramount for your success. OSI can assist you in preparing a competitive proposal and can help guide your efforts from the first draft of the pre-proposal to submission of the full application.
Timeline: Invitation to submit a Full proposal will be given within 90 days of submission of the pre-proposal. An additional 90 days is provided to the applicant to complete the full application. Allow for at least 6 months between submission of the whitepaper to submission of the full application.
Contact us: If you are planning on submitting a pre-proposal, have questions, or would like more information - contact OSI Project Manager Irene Shaland - firstname.lastname@example.org - 216.368.4970
Division of Infectious Diseases & HIV Medicine, CWRU and UH Case Medical Center
Announcement of Infectious Diseases Research Support from STERIS Corporation
The Division of Infectious Diseases & HIV Medicine at Case Western Reserve University and University Hospitals Case Medical Center, with funds from STERIS Corporation, will provide seed money to faculty to foster research in emerging and healthcare-associated infections.
Announcement of Infectious Diseases Research Support from the Infectious Diseases & Immunology Institute (IDII)
The Infectious Diseases & Immunology Institute (IDII) at Case Western Reserve University will provide seed money to young investigators (within 5 years of appointment) to foster interdisciplinary research in infectious diseases and immunology.
For more information on these opportunities, please contact Martha Salata at 844-1988 or email@example.com or visit the Center’s website.
The Cleveland Area Reliant IRB Review Process
The Cleveland Area Reliant Institutional Review Board (IRB) Review process includes participation by the Case Western Reserve University (CWRU) Social, Behavioral, and Educational Research (SBER) IRB, the Cleveland Clinic (CC) IRB, MetroHealth Medical Center (MHMC) IRB, and University Hospitals Case Medical Center (UHCMC) IRB. The process relies on executed IRB Authorization Agreements (IAA) between the institutions. These agreements document that all applicable human research subjects protection considerations will be made by one Institutional Review Board (IRB), which will be deemed the IRB of record. The IRBs of the other Cleveland area institutions will accept the approval of the IRB of record through the Reliant Review process. The goal is to eliminate duplication of effort and multiple applications for submission of the same protocol, and to encourage scientific collaboration among the affiliated institutions.
What types of studies are eligible for the Reliant Review Process?
Any type of human research study could be eligible for the Reliant Review process. These include but are not limited to investigator-initiated, federally-funded, foundation-supported, industry-sponsored, and non-funded studies.
The fundamental requirement is that a collaborating investigator must be named at each site where the research will occur. It is important for the Principal Investigator at the lead study site to work with the IRB of record throughout the Reliant Review Process to initiate acceptance of IRB approval at each collaborating site.
For further information, contact Kim Volarcik at (216) 368-0134 or firstname.lastname@example.org.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
email@example.com no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be